INJECTABLE MAGNETIC PREPARATIONS

Brand	Owner (click to sort)	Address	Description
SIENNA PRIME	Endomagnetics Limited	Tower 42, 33rd Floor 25 Old Broad Street London EC2N1HQ United Kingdom	Injectable magnetic preparations in the nature of liquid injectables for use in medical diagnosis and treatment; injectable magnetic preparations in the nature of liquid injectables for use in cancer staging, screening or treatment;
SIENNOVA	Endomagnetics Limited	Tower 42, 33rd Floor 25 Old Broad Street London EC2N1HQ United Kingdom	Injectable magnetic preparations in the nature of liquid injectables for use in cancer staging, screening or treatment; Injectable magnetic preparations in the nature of liquid injectables containing magnetic nanoparticles for use in medical diagnosis and treatment of cancer; Injectable magnetic preparations in the nature of liquid injectables capable of producing a transient magnetic response for use in medical diagnosis and treatment of cancer;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

Injectable compositions containing gabapentin and processes for preparing sterile injectable compositions containing gabapentin are discussed. The process includes subjecting the compositions to heat. Heating results in increased production of gabapentin lactam, which has previously been shown to be toxic. Surprisingly, heated injectable compositions containing gabapentin are found to be non-toxic when administered intrathecally. Thus, heating for the purposes of sterilization or to assure sterility provides a viable option in the production of injectable compositions containing gabapentin.